Laboratory Stock Net Income

LH Stock  USD 218.46  1.89  0.87%   
Laboratory fundamentals help investors to digest information that contributes to Laboratory's financial success or failures. It also enables traders to predict the movement of Laboratory Stock. The fundamental analysis module provides a way to measure Laboratory's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Laboratory stock.
As of now, Laboratory's Net Income is increasing as compared to previous years. The Laboratory's current Net Income Applicable To Common Shares is estimated to increase to about 1.5 B, while Net Income Per E B T is projected to decrease to 0.42.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Laboratory Net Income Analysis

Laboratory's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Laboratory Net Income

513.85 Million

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current Laboratory Net Income

    
  379.2 M  
Most of Laboratory's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Laboratory is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Laboratory Net Income Historical Pattern

Today, most investors in Laboratory Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Laboratory's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's net income growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Laboratory net income as a starting point in their analysis.
   Laboratory Net Income   
       Timeline  
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Laboratory Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

(62.27 Million)

As of now, Laboratory's Accumulated Other Comprehensive Income is decreasing as compared to previous years.
Based on the recorded statements, Laboratory reported net income of 379.2 M. This is 11.11% higher than that of the Health Care Providers & Services sector and 119.05% higher than that of the Health Care industry. The net income for all United States stocks is 33.59% higher than that of the company.

Laboratory Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Laboratory's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Laboratory could also be used in its relative valuation, which is a method of valuing Laboratory by comparing valuation metrics of similar companies.
Laboratory is currently under evaluation in net income category among related companies.

Laboratory ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.
Environment Score
Governance Score
Social Score

Laboratory Institutional Holders

Institutional Holdings refers to the ownership stake in Laboratory that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Laboratory's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Laboratory's value.
Shares
Norges Bank2023-12-31
1.3 M
Bank Of America Corp2023-12-31
1.3 M
Ubs Asset Mgmt Americas Inc2023-12-31
1.2 M
Northern Trust Corp2023-12-31
1.2 M
Veritas Investment Partners (uk) Ltd.2023-12-31
1.1 M
Amvescap Plc.2023-12-31
1.1 M
Fmr Inc2023-12-31
1.1 M
Allspring Global Investments Holdings, Llc2023-12-31
M
Nuveen Asset Management, Llc2023-12-31
920.5 K
Blackrock Inc2023-12-31
10.5 M
Vanguard Group Inc2023-12-31
9.7 M

Laboratory Fundamentals

About Laboratory Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Laboratory's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Net Income379.2 M514.7 M
Net Income Applicable To Common Shares1.5 B1.5 B
Net Income From Continuing Ops861.4 M880.6 M
Net Income Per E B T 0.73  0.42 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Stock:
Check out Laboratory Piotroski F Score and Laboratory Altman Z Score analysis.
For more detail on how to invest in Laboratory Stock please use our How to Invest in Laboratory guide.
Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.46)
Dividend Share
2.88
Earnings Share
4.33
Revenue Per Share
139.628
Quarterly Revenue Growth
0.035
The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.